Ординатура / Офтальмология / Учебные материалы / Clinical Diagnosis and Management of ocular trauma
.pdf176 |
|
Clinical Diagnosis and Management of Ocular Trauma |
|
||
|
SYSTEMIC ANTIBIOTICS |
after periocular antibiotic injection have been |
|||
|
|
||||
|
|
The systemic antibiotics that cross the blood retinal |
reported.29 In addition, subconjunctival injection is |
||
|
|
barrier include cefazolin, ceftazidime and cipro- |
more painful and could not be as frequently |
||
|
|
floxacin.21-23 In the EVS, intravenous ceftazidime and |
administrated as topical antibiotics. A risk of macular |
||
|
|
amikacin were evaluated, and it was concluded that |
infarction when using gentamicin has also been |
||
|
|
these antibiotics did not alter final visual acuity or media |
reported.14 Of the currently used antibiotics, the third- |
||
|
|
clarity.10 However, subsequent to the publication, this |
generation cephalosporins |
(ceftazidime and |
|
|
|
conclusion has come under question. First, these two |
ceftriaxone) achieve the highest vitreous levels. |
||
|
|||||
|
|
drugs did not cover the most common micro-organisms |
Topical application is associated with very poor |
||
|
|
of gram-positive bacteria in postoperative endoph- |
vitreous penetration. However, significant intraocular |
||
|
|
thalmitis. Second, intravenous amikacin has little |
levels of antibiotics can be achieved with frequent |
||
|
|
intraocular penetration. The recommendation against |
administration of highly concentrated solutions30, |
||
|
|
intravenous antibiotic use was not warranted and might |
especially if the corneal epithelium has been damaged. |
||
|
|
be based on inadequate data. |
For acute-onset postoperative endophthalmitis, topical |
||
|
|
Intravenous vancomycin has been suggested as an |
vancomycin (50 mg/mL) with amikacin (20 mg/mL) |
||
|
|
alternative therapy to systemic ceftazidime and amika- |
or ceftazidime (50 mg/mL) administered hourly is |
||
|
|
cin because of its superior gram-positive coverage. |
recommended. This regimen can then be adjusted for |
||
|
|
However, vancomycin penetrates poorly into the |
the specific organism after culture and sensitivity results |
||
|
|
vitreous yielding an inadequate antibacterial effect.24,25 |
are available. |
|
|
|
|
Oral ciprofloxacin might be an effective drug against |
STEROID TREATMENT |
|
|
|
|
many common infecting organisms causing endoph- |
|
||
|
|
thalmitis.26 However, older-generation fluoroquino- |
The early use of corticosteroids, in addition to antibiotics, |
||
|
|
lones (ciprofloxacin, ofloxacin and levofloxacin) are |
reduces inflammation and subsequent retinal damage |
||
|
|
increasingly ineffective against some of the pathogens |
in endophthalmitis. Corticosteroid therapy may be |
||
|
|
most commonly responsible for postoperative |
administered topically, intravitreally or systemically. In |
||
|
|
endophthalmitis. In contrast, the newer-generation |
the EVS, oral prednisone was used at a dose of 30 mg |
||
|
|
fluoroquinolones (gatifloxacin and moxifloxacin) show |
orally twice a day for 5 to 10 days. |
||
|
|
promising results; they not only display effective activity |
Intravitreous dexamethasone has been increasingly |
||
|
|
against gram-negative bacteria, as do the older- |
employed as an alternative to systemic therapy. |
||
|
|
generation fluoroquinolones, but also demonstrate |
Dexamethasone sodium phosphate is typically used |
||
|
|
enhanced potencies against gram-positive bacteria.27 |
in an intravitreous concentration of 0.4 mg/0.1 mL. |
||
|
|
Orally administered gatifloxacin was able to penetrate |
This is equivalent to 40 mg of oral prednisone. |
||
|
|
into the non-inflamed human eye, and reach |
Experimental studies have shown that intravitreal |
||
|
|
therapeutic levels in the aqueous and vitreous |
dexamethasone has a large safety window and that |
||
|
|
humors.28 Gatifloxacin has a broad spectrum of |
it prolongs the half-life of intravitreal vancomycin.31,32 |
||
|
|
coverage over the bacteria involved in endophthalmitis. |
Triamcinolone acetonide (4 mg/0.1 mL) is more potent |
||
|
|
It also has a low MIC of 90, good tolerability and |
and equivalent to 50 mg of oral prednisone. Recently |
||
|
|
excellent bioavailability after oral administration. Oral |
it has been reported that intravitreal triamcinolone |
||
|
|
gatifloxacin has the ability to achieve rapid, effective |
combined with intravitreal antibiotics appear to have |
||
|
|
levels in the aqueous and vitreous, with the notable |
|
|
|
|
|
exceptions of not achieving effective levels against |
|
|
|
|
|
TABLE 29.3: Recommended doses of initial management |
|||
|
|
Enterococcus or Pseudomonas. Gatifloxacin may thus |
|||
|
|
represent a good adjunctive treatment for certain types |
of infective postoperative endophthalmitis |
||
|
|
of endophthalmitis. |
Route |
Drug |
Dose |
|
|
|
|
|
|
|
|
SUBCONJUNCTIVALAND TOPICAL |
Intravitreal |
Vancomycin |
1 mg in 0.1mL |
|
|
|
Ceftazidime |
2.25 mg in 0.1mL |
|
|
|
ANTIBIOTIC THERAPY |
|
Amikacin |
0.4 mg in 0.1mL |
|
|
Subconjunctival and topical antibiotics are often used |
|
Dexamethasone |
0.4 mg in 0.1mL |
|
|
Subconjunctival |
Vancomycin |
25 mg in 0.5mL |
|
|
|
to supplement intravitreal injections in attempt to |
|||
|
|
|
Ceftazidime |
100 mg in 0.5mL |
|
|
|
increase the concentration of antibiotics within the |
Topical |
Vancomycin |
50 mg/mL drop q1h |
|
|
anterior segment of the eye. Subconjunctival |
|
Amikacin |
20 mg/mL drops q1h |
|
|
administration can reach therapeutic concentrations |
Systemic |
Fluoroquinolones 400 mg bid |
|
|
|
in the eye, especially in the aqueous humor. However, |
|
(oral) |
|
|
|
|
Gatifloxacin |
|
|
|
|
conflicting data regarding the intravitreal penetration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Management of Endophthalmitis |
|
|
|
177 |
|||
|
a safety profile similar to current modalities, with a |
vitrectomy in conjunction with intraocular antibiotic |
|
|||||||
|
favorable effect on visual recovery and function in acute |
injection. Culture of vitreous fluid from a vitreous tap |
|
|||||||
|
postoperative endophthalmitis.33 |
|
|
or vitrectomy is essential for microbiology sensitivity |
|
|||||
|
|
|
|
|
patterns. The flow-chart for management of acute |
|
||||
|
VITRECTOMY |
|
|
|
endophthalmitis is shown in Figure 29.1. For |
|
||||
|
Vitrectomy debulks the vitreous cavity, reduces the load |
intravitreous antibiotic injection, we prefer intravitreal |
|
|||||||
|
vancomycin (1 mg) and ceftazidime (2.25 mg) or |
|
||||||||
|
of bacteria and |
toxins, and |
makes space |
for |
|
|||||
|
amikacin (0.4 mg) combined with intravitreal dexamet- |
|
||||||||
|
intravitreous antibiotics. Only core vitrectomy is |
|
||||||||
|
hasone (0.4 mg). The rationale and choice of systemic |
|
||||||||
|
recommended, due to fear of causing retinal break |
|
||||||||
|
antibiotics is best left to the treating physician. Systemic |
|
||||||||
|
as the vitrector is near to the fragile, inflamed retina |
|
||||||||
|
fluoroquinolone is suggested (Tables 29.3 to 29.5). |
|
||||||||
|
in a cloudy vitreous. In addition, it is always combined |
|
||||||||
|
|
|
|
|
|
|
||||
|
with intravitreous antibiotic injection. The EVS |
Chronic Postoperative |
|
|
|
|
||||
|
concluded that immediate vitrectomy was not beneficial |
|
|
|
|
|||||
|
for patients with an initial visual acuity of hand |
Endophthalmitis |
|
|
|
|
||||
|
movement or better.10 Among patients with initial light- |
|
|
|
|
|||||
|
perception-only vision, it was three times more likely |
There are two different types of chronic postoperative |
|
|||||||
|
that a visual acuity of 20/40 or better would be achieved |
endophthalmitis, one is caused by Propionibacterium |
|
|||||||
|
after vitrectomy. Complications of pars plana |
acnes and the other is caused by fungus. These |
|
|||||||
|
vitrectomy include infection, bleeding, cataract, |
microorganisms should be considered especially when |
|
|||||||
|
glaucoma and retinal detachment. |
|
the initial culture result is negative. The culture plates |
|
||||||
|
In summary, the authors recommend the following |
should be investigated for at least 2 weeks. However, |
|
|||||||
|
for management of acute postoperative endophthal- |
the culture rate is very low. Polymerase chain reaction |
|
|||||||
|
mitis. Noting the patient’s unusual symptoms, carefully |
(PCR) detection of bacterial DNA with specific primers |
|
|||||||
|
examining signs associated with infection and a highly |
from vitreous samples may prove a useful means of |
|
|||||||
|
alert mind in the physician are important in early |
diagnosing delayed postoperative endophthalmitis.34 |
|
|||||||
|
intervention, especially for immunocompromised and |
There are two important retrospective studies by |
|
|||||||
|
diabetic patients. It is good to initiate topical antibiotics |
Aldave et al35 and Clark et al36 on P. acnes induced |
|
|||||||
|
and cycloplegics immediately during close follow-up |
postoperative endophthalmitis. The choice for |
|
|||||||
|
when there is suspicion of infection. The current choice |
intravitreous antibiotic injection is vancomycin (1 mg |
|
|||||||
|
of drugs is ciprofloxacin 0.3% or ofloxacin 0.3%. If |
in 0.1 mL). However, intravitreous injection of |
|
|||||||
|
infection is strongly suspected, the presenting vision |
antibiotics alone is associated with a very high rate |
|
|||||||
|
is important in deciding between a vitreous tap and |
recurrence. Pars plana vitrectomy, partial capsulectomy |
|
|||||||
|
|
|
|
|
|
|
||||
|
|
TABLE 29.4: Antimicrobial agents: dosages for ophthalmic use |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
Drug |
Topical |
Subconj. |
Intravitreal |
Intravenous |
Oral dosage |
|
|
|
|
|
|
|
(in 0.5ml) |
(in 0.1ml) |
dose |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aminoglycosides |
|
|
|
|
|
|
|
|
|
|
Gentamicin |
14 mg/ml |
20 mg |
0.1 mg |
1.4 mg/kg q8-12hr |
|
|
|
|
|
|
Tobramycin |
14 mg/ml |
20 mg |
0.1 mg |
1.4 mg/kg IV, IV, q8-12hr |
|
|
|
|
|
|
Amikacin |
20 mg/ml |
25-50 mg |
0.4 mg |
7.5 mg/kg q12hr |
|
|
|
|
|
|
Cephalosporins |
|
|
|
|
|
|
|
|
|
|
Cefazolin |
50 mg/ml |
50 mg |
2.0 mg |
1 g q8h |
|
|
|
|
|
|
Cefotetan |
|
|
3.0 mg |
1 g q12h |
|
|
|
|
|
|
Ceftriaxone |
|
|
2.0 mg |
1-2 g q8h |
|
|
|
|
|
|
Ceftazidime |
50 mg/ml |
100 mg |
2.25 mg |
1-2 g q8h |
|
|
|
|
|
|
Penicillins |
|
|
|
|
|
|
|
|
|
|
Oxacillin |
50 mg/ml |
|
0.5 mg |
2 g q4h |
500 mg qid |
|
|
|
|
|
Miscellaneous |
|
|
|
|
|
|
|
|
|
|
Clindamycin |
20 mg/ml |
15-40 mg |
1 mg |
|
600 mg q8h |
150-450 mg qid |
|
|
|
|
Ciprofloxacin |
0.3% |
|
0.1 mg |
400 mg q12h |
500-750 mg bid |
|
|
|
|
|
Gatifloxacin |
|
|
|
|
|
400 mg bid |
|
|
|
|
Chloramphenicol |
5 mg/ml |
|
2 mg |
|
750 mg q6h |
250-750 mg qid |
|
|
|
|
Erythromycin |
10 mg/ml |
|
0.5 mg |
500-1000 mg q6h |
250-500 mg qid |
|
|
|
|
|
Vancomycin |
50 mg/ml |
25 mg |
1-2 mg |
1 g q12h |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
178 |
|
Clinical Diagnosis and Management of Ocular Trauma |
|
and intravitreous antibiotic injection without intraocular |
|
|
|
|
|
|
lens (IOL) exchange are usually successful on long- |
|
|
term follow-up. For patients with recurrent intraocular |
|
|
inflammation, pars plana vitrectomy, total capsular bag |
|
|
removal, intravitreous antibiotic injection and IOL |
|
|
exchange or removal is a uniformly successful strategy. |
|
|
Recommended treatment for chronic fungal |
|
|
endophthalmitis is pars plana vitrectomy and intravitreal |
|
||
|
|
injection of amphotericin B (5-10 μg in 0.1 mL).37 |
|
|
Effective systemic amphotericin concentration is still |
|
|
unknown. In cases of yeast endophthalmitis (i.e. |
|
|
Candida species), high doses of oral fluconazole (400- |
|
|
600 mg/day) are recommended.38 |
IOAB: Intraocular antibiotics
Fig. 29.1: Flow-chart for the manage of acute postoperative endophthalmitis
BLEB-ASSOCIATED ENDOPHTHALMITIS
It is important to distinguish between a localized bleb infection (blebitis) and true bleb-associated endophthalmitis. In cases of blebitis, topical antibiotics and subconjunctival antibiotics, such as vancomycin and ceftazidime, can usually be given in an out-patient setting.39 Bleb-associated endophthalmitis is typically characterized by a delayed onset, more virulent pathogens and poor visual prognosis. Due to the more virulent microorganisms (Streptococcus species and Haemophilus influenzae) and resulting poor visual prognosis, immediate pars plana vitrectomy, and intravitreal injection of vancomycin and ceftazidime are recommended.40 Topical and systemic antibiotics (vancomycin and ceftazidime) should be used.
POST-TRAUMATIC ENDOPHTHALMITIS
Due to the initial injury, delay in primary wound repair and more virulent organisms (Bacillus or Staphylococcus species), post-traumatic endophthalmitis generally has a worse visual outcome than other categories. Endophthalmitis caused by Bacillus species
TABLE 29.5: Antifungal dosages in ophthalmic use
Drug |
Topical |
Subconj |
Intravitreal |
Usual intravenous |
Oral dosage |
|
|
(in 0.5 ml) |
(in 0.1 ml) |
dose |
|
|
|
|
|
|
|
Polyenes |
|
|
|
|
|
Amphotericin B |
2.5-10 mg/ml |
300 µg |
5-10 µg/ml |
1mg/kg/day |
|
Natamycin |
5% |
|
|
|
|
Nystatin |
100,000 U/g |
|
|
|
|
Imidazoles |
ointment |
|
|
|
|
|
|
|
|
|
|
Fluconazole |
2% |
|
|
|
400 mg/day |
Clotrimazole |
1% |
5-10 mg |
|
|
60-150 mg/kg/day |
Econazole |
1% |
|
|
30 mg/kg/day |
200 mg tid |
Ketoconazole |
1-5% |
|
|
|
200-400 mg/day |
Miconazole |
1% |
5-10 mg |
0.25 mg |
25 mg/kg/day in |
|
Thiabendazole |
4% |
|
|
2-3 divided doses |
25 mg/kg/day |
|
|
|
|||
Pyrimidines |
|
|
|
|
|
Flucytosine |
1% |
|
|
|
50-150 mg/kg/day |
Management of Endophthalmitis |
|
|
179 |
|||
is characterized by a rapidly progressive course, ring |
phthalmitis” that resolves without invasive treatment, |
|
||||
corneal infiltrates and, generally, a poor visual |
which might be caused by triamcinolone crystal in the |
|
||||
outcome, even with prompt therapy.41 Prophylactic |
anterior chamber or an inflammatory reaction to the |
|
||||
intravitreal broad spectrum antibiotic injection |
solvent toxin. Infectious endophthalmitis usually |
|
||||
decreases the risk of post-traumatic endophthalmitis.42 |
manifests acutely or subacutely with pain. It was |
|
||||
In addition, systemic antibiotics are usually |
concluded that in certain eyes injected with |
|
||||
administered.43 |
triamcinolone, the differential diagnosis should include |
|
||||
|
|
a sterile, toxic endophthalmitis and it may be |
|
|||
|
|
|
||||
Endogenous Endophthalmitis |
appropriate to observe the patient closely every 8 to |
|
||||
12 hours to determine if the inflammation is worsening |
|
|||||
|
|
or improving. However, if new symptoms develop |
|
|||
Endogenous endophthalmitis is more commonly |
|
|||||
more than several days after injection, infectious |
|
|||||
diagnosed in immunocompromised and debilitated |
|
|||||
endophthalmitis should be presumed and treatment |
|
|||||
patients. Once the diagnosis of endophthalmitis is |
|
|||||
initiated immediately.48 |
|
|
|
|||
suspected, blood or urine cultures should be obtained |
|
|
|
|
|
|
and other organ involvement must be sought by |
|
|
|
|
|
|
consultation with an infectious disease specialist or |
Conclusion |
|
|
|
||
internist. The use of systemic antibiotics is also usually |
|
|
|
|||
|
|
|
|
|
||
undertaken. |
Early recognition of endophthalmitis, together with |
|
||||
Candida albicans is the most common organism |
appropriate and timely treatment, can often reduce |
|
||||
causing endogenous fungal endophthalmitis and |
visual loss. |
|
|
|
||
Aspergillus species is the second most common fungal |
|
|
|
|
|
|
cause.44 The management of endogenous Candida |
References |
|
|
|
||
endophthalmitis is generally tailored to the clinical |
|
|
|
|||
situation. When chorioretinal infiltrates are present with |
|
|
|
|
|
|
1. |
Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis |
|
||||
no or minimal vitreous involvement, systemic therapy |
|
|||||
|
prophylaxis for cataract surgery: an evidence-based |
|
||||
alone is recommended. With moderate or severe vitritis, |
|
|
||||
|
update. Ophthalmology 2002;109(1):13-24. |
|
|
|
||
or deterioration in spite of systemic therapy, vitrectomy |
|
|
|
|
||
2. |
Saggers BA, Stewart GT. Polyvinyl-Pyrrolidone-Iodine: |
|
||||
and intraocular amphotericin B are recommended. |
|
An Assessment of Antibacterial Activity. J Hyg (Lond) |
|
|||
Endogenous bacterial endophthalmitis often is an |
|
1964;62:509-18. |
|
|
|
|
initial finding leading to the diagnosis of bacterial |
3. |
Connell JF, Jr., Rousselot LM. Povidone-Iodine. Extensive |
|
|||
endocarditis, sepsis and liver abscess in Asians. In |
|
Surgical Evaluation of a New Antiseptic Agent. Am J Surg |
|
|||
patients with diabetes and liver abscess, endogenous |
|
1964;108:849-55. |
|
|
|
|
4. |
Berkelman RL, Lewin S, Allen JR, |
et al. |
|
|||
Klebsiella pneumoniae endophthalmitis is endemic in |
|
|||||
|
Pseudobacteremia attributed to contamination of |
|
||||
the Chinese population.45 It is a very fulminant infection |
|
|
||||
|
povidone-iodine with Pseudomonas cepacia. Ann Intern |
|
||||
and often results in poor visual outcome. Prompt |
|
Med 1981;95(1):32-36. |
|
|
|
|
diagnosis and vigorous treatment with intravitreous |
5. |
Johns KJ, Feder RS, Hamill MB, Miller-Meeks MJ. |
|
|||
injections of vancomycin, amikacin and dexametha- |
|
Surgery for Cataract. In: Johns KJ, Feder RS, Hamill MB, |
|
|||
sone within 24 hours can save the patient’s eyes and |
|
Miller-Meeks MJ, eds. Basic and Clinical Science Course |
|
|||
vision.46 Systemic antibiotics and intraocular antibiotics |
|
Section 11: Lens and Cataract: American Academy of |
|
|||
|
Ophthalmology 2003-04. |
|
|
|
||
are recommended. Early vitrectomy for endogenous |
|
|
|
|
||
6. |
Ferguson AW, Scott JA, McGavigan J, et al. Comparison |
|
||||
Klebsiella pneumoniae endophthalmitis might be |
|
|||||
|
of 5% povidone-iodine solution against 1% povidone- |
|
||||
beneficial.47 However, debilitation and confinement in |
|
iodine solution in preoperative cataract surgery antisepsis: |
|
|||
bed because of the sickness in these patients often |
|
a prospective randomised double blind study. Br J |
|
|||
results in it being unlikely that anesthesia and surgery |
7. |
Ophthalmol 2003;87(2):163-67. |
|
|
|
|
can be performed in the operating room. |
Ta CN. Minimizing the risk of endophthalmitis following |
|
||||
|
intravitreous injections. Retina 2004;24(5):699-705. |
|
||||
|
|
|
|
|||
|
|
8. |
Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and |
|
||
Intravitreous Triamcinolone- |
|
susceptibilities of microbiologic isolates in the Endo- |
|
|||
|
phthalmitis Vitrectomy Study. Am J Ophthalmol |
|
||||
associated Endophthalmitis |
|
|
1996;122(1):1-17. |
|
|
|
9. |
Pflugfelder SC, Hernandez E, Fliesler SJ, et al. Intravitreal |
|
||||
Triamcinolone injection has become popular for |
|
vancomycin. Retinal toxicity, clearance, and interaction |
|
|||
|
with gentamicin. Arch Ophthalmol 1987;105(6):831-37. |
|
||||
treating macula edema in many diseases. Although |
|
|
||||
10. |
Results of the Endophthalmitis Vitrectomy Study. A |
|
||||
some patients appear to have an infectious endo- |
|
|||||
|
randomized trial of immediate vitrectomy and of |
|
||||
phthalmitis, many reports detail a “pseudoendo- |
|
intravenous antibiotics for the treatment of postoperative |
|
|||
|
|
|
|
|
|
|
180 |
|
|
Clinical Diagnosis and Management of Ocular Trauma |
||
|
|
bacterial endophthalmitis. Endophthalmitis Vitrectomy |
29. |
Foster RE, Rubsamen PE, Joondeph BC, et al. |
|
|
|
|
|||
|
|
|
Study Group. Arch Ophthalmol 1995;113(12):1479-96. |
|
Concurrent endophthalmitis and retinal detachment. |
|
11. |
Coco RM, Lopez MI, Pastor JC, Nozal MJ. Pharmaco- |
|
Ophthalmology 1994;101(3):490-98. |
|
|
|
|
kinetics of intravitreal vancomycin in normal and infected |
30. |
Barza M. Antibacterial agents in the treatment of ocular |
|
|
|
rabbit eyes. J Ocul Pharmacol Ther 1998;14(6):555-63. |
|
infections. Infect Dis Clin North Am 1989;3(3):533-51. |
|
12. |
Kwok AK, Hui M, Pang CP, et al. An in vitro study of |
31. |
Kwak HW, D’Amico DJ. Evaluation of the retinal toxicity |
|
|
|
|
ceftazidime and vancomycin concentrations in various |
|
and pharmacokinetics of dexamethasone after intravitreal |
|
|
|
fluid media: implications for use in treating endophthal- |
|
injection. Arch Ophthalmol 1992;110(2):259-66. |
|
|
|
mitis. Invest Ophthalmol Vis Sci 2002;43(4):1182-88. |
32. |
Park SS, Vallar RV, Hong CH, et al. Intravitreal |
|
|
|
|||
|
13. |
Tanabe J, Kitano K, Suzuki T, et al. Nontoxic concen- |
|
dexamethasone effect on intravitreal vancomycin |
|
|
|
|
tration of ceftazidime and flomoxef sodium for intravitreal |
|
elimination in endophthalmitis. Arch Ophthalmol |
|
|
|
use—evaluated by in-vitro ERG. Lens Eye Toxic Res |
|
1999;117(8):1058-62. |
|
|
|
1990;7(3-4):677-83. |
33. |
Falk NS, Beer PM, Peters GB, 3rd. Role of intravitreal |
|
14. |
Campochiaro PA, Conway BP. Aminoglycoside toxicity— |
|
triamcinolone acetonide in the treatment of postoperative |
|
|
|
|
a survey of retinal specialists. Implications for ocular use. |
|
endophthalmitis. Retina 2006;26(5):545-48. |
|
|
|
Arch Ophthalmol 1991;109(7):946-50. |
34. |
Hykin PG, Tobal K, McIntyre G, et al. The diagnosis of |
|
15. |
D’Amico DJ, Caspers-Velu L, Libert J, et al. Comparative |
|
delayed post-operative endophthalmitis by polymerase |
|
|
|
|
toxicity of intravitreal aminoglycoside antibiotics. Am J |
|
chain reaction of bacterial DNA in vitreous samples. J |
|
|
|
Ophthalmol 1985;100(2):264-75. |
|
Med Microbiol 1994;40(6):408-15. |
|
16. |
Campochiaro PA, Lim JI. Aminoglycoside toxicity in the |
35. |
Aldave AJ, Stein JD, Deramo VA, et al. Treatment |
|
|
|
|
treatment of endophthalmitis. The Aminoglycoside |
|
strategies for postoperative Propionibacterium acnes |
|
|
|
Toxicity Study Group. Arch Ophthalmol 1994;112(1): |
|
endophthalmitis. Ophthalmology 1999;106(12):2395- |
|
|
|
48-53. |
|
401. |
|
17. |
Kumar A, Dada T. Preretinal haemorrhages: an unusual |
36. |
Clark WL, Kaiser PK, Flynn HW, Jr., et al. Treatment |
|
|
|
|
manifestation of intravitreal amikacin toxicity. Aust N Z |
|
strategies and visual acuity outcomes in chronic |
|
|
|
J Ophthalmol 1999;27(6):435-36. |
|
postoperative Propionibacterium acnes endophthalmitis. |
|
18. |
Seawright AA, Bourke RD, Cooling RJ. Macula toxicity |
|
Ophthalmology 1999;106(9):1665-70. |
|
|
|
|
after intravitreal amikacin. Aust N Z J Ophthalmol |
37. |
Ciulla TA. Update on acute and chronic endophthalmitis. |
|
|
|
1996;24(2):143-46. |
|
Ophthalmology 1999;106(12):2237-38. |
|
|
19. Mandell BA, Meredith TA, Aguilar E, et al. Effects of |
38. |
Luttrull JK, Wan WL, Kubak BM, et al. Treatment of ocular |
|
|
|
|
inflammation and surgery on amikacin levels in the |
|
fungal infections with oral fluconazole. Am J Ophthalmol |
|
|
|
vitreous cavity. Am J Ophthalmol 1993;115(6):770-74. |
|
1995;119(4):477-81. |
|
20. |
Shaarawy A, Grand MG, Meredith TA, Ibanez HE. |
39. |
Chen PP, Gedde SJ, Budenz DL, Parrish RK, 2nd. |
|
|
|
|
Persistent endophthalmitis after intravitreal antimicrobial |
|
Outpatient treatment of bleb infection. Arch Ophthalmol |
|
|
|
therapy. Ophthalmology 1995;102(3):382-87. |
|
1997;115(9):1124-28. |
|
21. |
Aguilar HE, Meredith TA, Shaarawy A, et al. Vitreous |
40. |
Kangas TA, Greenfield DS, Flynn HW, Jr., et al. Delayed- |
|
|
|
|
cavity penetration of ceftazidime after intravenous |
|
onset endophthalmitis associated with conjunctival |
|
|
|
administration. Retina 1995;15(2):154-59. |
|
filtering blebs. Ophthalmology 1997;104(5):746-52. |
|
22. |
Keren G, Alhalel A, Bartov E, et al. The intravitreal pene- |
41. |
Foster RE, Martinez JA, Murray TG, et al. Useful visual |
|
|
|
|
tration of orally administered ciprofloxacin in humans. |
|
outcomes after treatment of Bacillus cereus endophthal- |
|
|
|
Invest Ophthalmol Vis Sci 1991;32(8):2388-92. |
|
mitis. Ophthalmology 1996;103(3):390-97. |
|
23. |
Martin DF, Ficker LA, Aguilar HA, et al. Vitreous cefazolin |
42. |
Narang S, Gupta V, Gupta A, et al. Role of prophylactic |
|
|
|
|
levels after intravenous injection. Effects of inflammation, |
|
intravitreal antibiotics in open globe injuries. Indian J |
|
|
|
repeated antibiotic doses, and surgery. Arch Ophthalmol |
|
Ophthalmol 2003;51(1):39-44. |
|
|
|
1990;108(3):411-14. |
43. |
Reynolds DS, Flynn HW, Jr. Endophthalmitis after |
|
24. |
Ferencz JR, Assia EI, Diamantstein L, Rubinstein E. Vanco- |
|
penetrating ocular trauma. Curr Opin Ophthalmol |
|
|
|
|
mycin concentration in the vitreous after intravenous and |
|
1997;8(3):32-38. |
|
|
|
intravitreal administration for postoperative endophthal- |
44. |
Weishaar PD, Flynn HW, Jr., Murray TG, et al. Endogen- |
|
|
|
mitis. Arch Ophthalmol 1999;117(8):1023-27. |
|
ous Aspergillus endophthalmitis. Clinical features and |
|
25. |
Souli M, Kopsinis G, Kavouklis E, et al. Vancomycin levels |
|
treatment outcomes. Ophthalmology 1998;105(1):57-65. |
|
|
|
|
in human aqueous humour after intravenous and |
45. |
Chen YJ, Kuo HK, Wu PC, et al. A 10-year comparison |
|
|
|
subconjunctival administration. Int J Antimicrob Agents |
|
of endogenous endophthalmitis outcomes: an east Asian |
|
|
|
2001;18(3):239-43. |
|
experience with Klebsiella pneumoniae infection. Retina |
|
26. |
Das T, Sharma S. Current management strategies of acute |
|
2004;24(3):383-90. |
|
|
|
|
post-operative endophthalmitis. Semin Ophthalmol |
46. |
Chou FF, Kou HK. Endogenous endophthalmitis |
|
|
|
2003;18(3):109-15. |
|
associated with pyogenic hepatic abscess. J Am Coll Surg |
|
27. |
Mather R, Karenchak LM, Romanowski EG, Kowalski RP. |
|
1996;182(1):33-36. |
|
|
|
|
Fourth generation fluoroquinolones: new weapons in the |
47. |
Yoon YH, Lee SU, Sohn JH, Lee SE. Result of early |
|
|
|
arsenal of ophthalmic antibiotics. Am J Ophthalmol |
|
vitrectomy for endogenous Klebsiella pneumoniae |
|
|
|
2002;133(4):463-66. |
|
endophthalmitis. Retina 2003;23(3):366-70. |
|
28. |
Hariprasad SM, Mieler WF, Holz ER. Vitreous and |
48. |
Roth DB, Chieh J, Spirn MJ, et al. Noninfectious |
|
|
|
|
aqueous penetration of orally administered gatifloxacin |
|
endophthalmitis associated with intravitreal triamcinolone |
|
|
|
in humans. Arch Ophthalmol 2003;121(3):345-50. |
|
injection. Arch Ophthalmol 2003;121(9):1279-82. |
|
|
|
|
|
|
C H A P T E R
30Management of Pediatric
Ocular Trauma
Yog Raj Sharma, Ritesh Gupta, Rajni Sharma (India)
Introduction
Ocular trauma is a leading cause of unilateral blindness in children. The American Academy of Pediatrics (AAP) (1987) reported that 66% of all ocular injuries occur in persons 16 years of age or younger, with the highest frequency between 9 and 11 years of age. Virtually all studies of pediatric ocular trauma show a male to female predominance of approximately 4:1 attributed in part to boys more frequently choices of sharp and pointed play objects.1-6 Sports equipment especially cricket ball, stones, wooden sticks (Gilli danda),1 fire-crackers,2 bow and arrow,1etc. are the items most often implicated. Pediatric ocular trauma occurs most often during play that is not supervised by an adult (AAP1987).
Other ocular disorders may be noticed first after even subtle trauma. An injury may bring to light preexisting leukocoria, strabismus or proptosis. Therefore one should always consider nontrauma etiologies in the evaluation of injured child.
Caring for children with ocular trauma involves several distinctive aspects such as:
•The possibility of prenatal injuries
•Diagnostic challenges due to limitations experienced during history taking and examination
•The developing visual system and the potential for amblyopia
•An orbit that is immature (cosmesis following enucleation and evisceration)
•Predisposition to certain types of trauma (e.g. firecrackers or toys related).
Evaluation
HISTORY
Evaluation of ocular trauma requires a thorough history, preferably from the child. Keep in mind that a child may fabricate a history if involved in a forbidden activity when injured. Likewise, parents may withhold
information if they feel that their negligence contributed to the accident. Some of the key information that needs to be gathered is given below:
•Mechanism of injury
•Exact time and place of injury
•Visual status before the trauma
•Any history of strabismus, congenital abnormalities ocular surgery, injury, patching or glasses
•Child’s general medical status before trauma
•Child’s tetanus immunization status
•Loss of vision, floaters or flashes of light.
EXAMINATION
It is important to establish a routine to assure a complete assessment. Examination of a child who has sustained ocular trauma is often difficult and frightening for both the child and the ophthalmologist. Patience, gentle technique, careful preparation and attention to detail provide the best outcome for everyone. Noncontact parts of the examination should be performed first. No external pressure should be exerted on the globe at any time during the examination.
If an infant or toddler is extremely uncooperative, restraining in a papoose board may become necessary. A wire eyelid speculum may be needed to retract the eyelids. It should be used only when it is certain that the globe is not ruptured or lacerated.
Toddlers may be restrained in a position in which parent and assistant hold the child and the ophthalmologist examines the child.
In cases where above measures do not allow adequate examination, appropriate sedation (e.g. Chloral hydrate 25-100 mg/kg, p.o.) should be used. Sedation of the pediatric patient may be complicated by vomiting, anaphylaxis, seizure, airway obstruction or cardiorespiratory arrest. Sedation should only be performed in a facility where the child’s vital signs are monitored and resuscitation and ventilatory equipment are at hand. It is advisable that an anesthetist or a pediatrician be present while sedating a child.
182 |
|
|
Clinical Diagnosis and Management of Ocular Trauma |
|
|
Visual Acuity |
Management—in most cases the injury is self limited, |
||
|
|
|||
|
|
Determination of visual acuity is the single most |
requiring no treatment. Persistent eyelid closure may |
|
|
|
important aspect of the ocular examination. Measure |
produce monocular amblyopia. The patient should |
|
|
|
the visual acuity of each eye separately. With a co- |
be followed periodically to assess visual development |
|
|
|
operative child, a Snellen chart, tumbling E , or illiterate |
and presence of astigmatism. Correction of refractive |
|
|
|
eye chart is used. In younger children, visual acuity |
error may be necessary to prevent amblyopia. |
|
|
|
is assessed by fixation and ability to follow target. |
Corneal Damage (Breaks in Descemet’s Membrane) |
|
|
|
|
|
|
|
|
Ocular Examination |
Corneal trauma is usually caused by the use of forceps |
|
|
|
during delivery. The resulting corneal edema is localized |
||
|
|
Estimate visual fields by bringing an object into the |
||
|
|
to the area of the break and usually clears within weeks |
||
|
|
child’s view from multiple angles. |
||
|
|
without intervention. Although there generally is vision |
||
|
|
|
Examine the eyelids and lacrimal drainage system |
|
|
|
|
loss with this condition caused by amblyopia and high |
|
|
|
to detect possible injuries. Gently palpate the orbital |
||
|
|
refractive errors,8 corneal transplantation is usually not |
||
|
|
rim for any irregularities or crepitus. Examine and |
||
|
|
necessary. |
||
|
|
record each pupil’s size, shape and reaction to light. |
||
|
|
|
||
|
|
Examine the conjunctiva and sclera to identify |
Retinal Hemorrhages |
|
|
|
lacerations, perforations or foreign bodies. |
||
|
|
Retinal hemorrhages are seen in about 20% of |
||
|
|
|
If an open globe is suspected, examination should |
|
|
|
|
newborn infants within 24 hours of birth.9 These |
|
|
|
be stopped at this point to prevent further injury to |
||
|
|
hemorrhages usually resolve quickly—and are seen |
||
|
|
the eye. A large eye shield or pad and bandage (not |
||
|
|
in fewer than 3% of infants by day 5 of life. These |
||
|
|
pressure patch) should be applied over the eye. The |
||
|
|
are more likely to be seen after forceps or vacuum |
||
|
|
remainder of the examination should be performed |
||
|
|
extraction deliveries. And are seen in fewer than 1% |
||
|
|
under general anesthesia. |
||
|
|
of cesarean deliveries. |
||
|
|
|
Assess intraocular pressure with Goldmann |
|
|
|
|
These should be observed to assure resolution. This |
|
|
|
applanation tonometer, Perkins tonometer, tono-pen |
||
|
|
usually occurs within a month. Diagnostic or |
||
|
|
or careful finger tip palpation. Stain the cornea with |
||
|
|
therapeutic intervention is usually not necessary. Child |
||
|
|
fluorescein paper and examine with slit lamp to identify |
||
|
|
abuse should be ruled out if it’s found after baby is |
||
|
|
abrasions. Examine anterior chamber fro hyphema, |
||
|
|
at home. |
||
|
|
hypopyon or other abnormalities. Evaluate the motility |
||
|
|
|
||
|
|
of both eyes after excluding globe perforation. A |
EYELID LACERATIONS |
|
|
|
dilated fundus exam (with or without scleral depression, |
||
|
|
as appropriate), is also essential during the trauma |
Lid lacerations may present with significant disfigure- |
|
|
|
examination. |
ment. Laceration involving medial side of the lid |
|
|
|
|
Obtain radiologic evaluation for injuries consistent |
(Figs 30.1A and B) may damage the lacrimal |
|
|
with orbital fractures or retained foreign body. |
drainage system. For superficial lacerations, clean the |
|
|
|
|
|
wound and surrounding skin with povidone iodine |
|
|
Specific Eye Injuries |
and irrigate thoroughly with saline, and remove any |
|
|
|
foreign material that may still be present. Then apply |
||
|
|
|
|
an antibacterial ointment and sterile dressing. |
|
|
Common eye injuries in children are discussed below |
||
|
|
For deeper lacerations, suturing with 8-0 silk or |
||
|
|
in |
brief. |
|
|
|
nylon is required. Complicated lacerations require an |
||
|
|
|
|
|
|
|
BIRTH TRAUMA |
oculoplastic surgeon consult. These are lacerations that |
|
|
|
have extensive tissue loss or have damaged the lacrimal |
||
|
|
Delivery may be associated with ocular and periocular |
drainage system, levator aponeurosis, and/or the |
|
|
|
injuries.7 Theseincludelidedema,subconjuctivalhemor- |
medial canthus tendon. |
|
|
|
rhage, corneal edema, corneal abrasion, hyphema, |
|
|
|
|
vitreous and retinal hemorrhage. The use of forceps |
CORNEAL AND CONJUNCTIVAL FOREIGN |
|
|
|
during delivery increases the chances of injury. |
BODIES (FIGS 30.2 AND 30.3A AND B) |
|
|
|
Periorbital Ecchymosis and Edema |
Patients can be completely asymptomatic, but generally |
|
|
|
foreign bodies cause mild to moderate eye pain |
||
|
|
Periorbital ecchymosis and edema are present after |
||
|
|
depending on their composition, location, and the |
||
|
|
birth. One needs to rule out other causes of lid closure |
patient’s pain tolerance. When examining a patient |
|
|
|
or swelling, e.g. congenital ptosis or conjunctivitis. |
with a possible foreign body, it is always important to |
|
|
|
|
|
|
Management of Pediatric Ocular Trauma |
183 |
|
|
|
|
Figs 30.1A and B: Lid laceration involving the medial canthal area. Lacrimal drainage system was unaffected in this patient
Fig. 30.2: Corneal foreign body
inspect the fornices thoroughly and evert the eyelids to look for occult palpebral conjunctival foreign bodies.
Before removing a corneal foreign body, always attempt to localize its depth because a penetrating
Figs 30.3A and B: A large foreign body located medial to limbus. It was found to be superficial and there was no penetrating trauma
object should be considered an open-globe injury and co-managed with an anterior segment or corneal subspecialist, when available. Superficial corneal foreign bodies are removed with a moistened cotton-tipped applicator or with the help of 26G needle after putting a drop of topical anesthetic solution. Patients may continue to report the sensation of a persistent foreign body even after removal of foreign body. This is usually because of small associated corneal epithelial defect. After the foreign body is removed, patch the eye for 12 to 24 hours with a topical antibiotic to allow the epithelium to heal.
SUBCONJUCTIVAL HEMORRHAGE
It can be caused by blunt trauma, forceful sneezing or eye rubbing. It usually results from breakage of the fragile conjunctival blood vessels. Whenever a traumatic subconjunctival hemorrhage occurs, a more severe underlying ocular injury, e.g. an occult scleral perforation or retained foreign body, etc. should be ruled out.
184 |
|
Clinical Diagnosis and Management of Ocular Trauma |
|
CORNEAL PENETRATION (FIGS 30.4AAND B) |
|
|
|
|
|
|
The Seidel test can be crucial in determining whether |
|
|
the patient has a fullor partial-thickness laceration. |
|
|
When examining these patients, gentle digital pressure |
|
|
may enhance the Seidel test and will allow a general |
|
|
assessment of the IOP if the depth of the laceration |
|
|
is uncertain. |
|
|
|
Fig. 30.4A: Large corneoscleral penetrating wound with hyphema and iris prolapse
Fig. 30.4B: Prolapsed iris excised and wound repaired using 10-0 monofilament nylon
TRAUMATIC HYPHEMA
Blunt ocular trauma can disrupt the vessels of iris and ciliary body resulting in hyphema (blood in the anterior chamber, Fig. 30.5). Hyphema without history of significant trauma should raise the suspicion of bleeding diatheses, leukemia, juvenile xanthogranuloma, iris neovascularization, retinoblastoma or fictitious history by the child. During the slit-lamp examination, it is of the utmost importance to grade the hyphema, because this will dictate both the management and follow-up of the condition.
|
Fig. 30.5: Hyphema |
|
Grading of hyphema |
|
|
Grade |
Percentage of anterior chamber filled |
|
with blood |
|
|
Microscopic |
Circulating red blood cells only |
I |
< 1/3 |
II |
1/3-1/2 |
III |
1/2- near total |
IV |
Total (eight-ball) |
|
|
The main goals of treatment are to normalize intraocular pressure and to minimize the likelihood of rebreeding. Rebleeding of a hyphema occurs in 5-33% of untreated eyes with hyphema and it typically occurs 2 to 5 days after the injury (when clot retraction and lysis are occurring).10, 11 Complications after hyphema are more common after rebleeding which may include corneal blood staining, optic atrophy, central retinal artery occlusion and peripheral anterior synechiae. The management of traumatic hyphema is controversial. But generally hospitalization with moderate restriction of physical activities is often recommended. Topical steroids are started to decrease anterior chamber inflammation. Atropine ointment1% or eye drops hommatropine 2% is given to keep the pupil in fixed and dilated position. (Short acting cycloplegic such as tropicamide is avoided as it may precipitate rebleeding.) Aminocaproic acid (antifibrinolytic agent) can stabilize clot formation at the site of hemorrhage and thus reduce the incidence of rebleed.12,13 It is given as 50 mg/kg, p.o., every 4 hourly for five days. Commonly encountered side effects are nausea, vomiting and postural hypotension. It is contraindicated in pregnant women.
Management of Pediatric Ocular Trauma |
185 |
Surgical drainage of hyphema is indicated if: 1. To prevent optic atrophy:
If IOP is more than 50 mm Hg for 5 days. If IOP is more than 35 mm Hg for 7 days.
2.To prevent corneal blood staining I eyes with a large hyphema:
If IOP is more than 25 mm Hg for 6 days. If there is any indication of blood staining.
3.To prevent peripheral anterior synechiae. If total hyphema persists for 5 days.
Various surgical techniques have been described to remove the blood. These include paracentesis, anterior chamber washout with one needle irrigation or irrigation-aspiration technique and clot evacuation with a forceps. Automated hyphemectomy (Figs 30.6A to C) using vitrectomy instruments inserted through limbal incisions permits controlled removal of blood in the anterior chamber.14, 15
TRAUMATIC CATARACT
It can be caused by both blunt and penetrating trauma. Blunt ocular trauma typically leads to stellate or rosetteshaped opacification which is usually axial in location and involves the posterior capsule. In perforating trauma, direct compromise of the lens capsule by penetrating object leads to cortical opacfication at the site of injury. If the perforation is small, then it may get sealed off and cataract remains localized whereas if the capsular tear is large, the entire lens can rapidly opacify.
Primary cataract extraction is indicated if there is obvious capsular rupture with lens matter in anterior chamber (Fig. 30.7) or when there is posterior segment injury (retinal detachment, endophthalmitis or intraocular foreign body) and the cataract disallows the proper management of these conditions. In all other cases, cataract surgery is deferred so that intraocular inflammation and hemorrhage subsides. The anterior approach (scleral tunnel or limbal or corneal incision) is the method of choice for cataract surgery. It should preferably be done by phacoemulsification with or without IOL implantation. This should be followed-up by rapid employment of optical correction and occlusion therapy to prevent amblyopia
if the child is less than 8 years old. Figs 30.6A to C: Hyphemectomy using vitrectomy instruments
VITREOUS AND RETINAL CONDITIONS
That can be caused by trauma are as follows:
Intraocular Foreign Body
Intraocular foreign body (IOFB) should be considered for all high-velocity ocular injuries, particularly those resulting from metal-on-metal activities.
One should particularly look for a self-sealing penetrating wound, iris hole, lens opacities, shallow anterior chamber, or low IOP in suspected IOFB cases. In many cases, IOFB can be identified by slit-lamp biomicroscopy or indirect ophthalmoscopy (Fig. 30.8). However, if the media is hazy or if foreign body is suspected but not visualized, imaging
